No abstract available
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Combined Modality Therapy
-
Female
-
Fibrinolytic Agents / administration & dosage*
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / therapeutic use
-
Fluid Therapy
-
Gastritis / etiology
-
Humans
-
Intestinal Perforation / complications
-
Intestinal Perforation / surgery
-
Middle Aged
-
Multiple Organ Failure / etiology
-
Peritonitis / drug therapy
-
Peritonitis / etiology
-
Postoperative Complications / drug therapy
-
Postoperative Complications / etiology
-
Postoperative Complications / therapy
-
Postoperative Hemorrhage / chemically induced*
-
Protein C / administration & dosage*
-
Protein C / adverse effects
-
Protein C / therapeutic use
-
Pseudomonas Infections / drug therapy*
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / therapeutic use
-
Recurrence
-
Respiration, Artificial
-
Respiratory Distress Syndrome / etiology
-
Respiratory Distress Syndrome / therapy
-
Shock, Septic / complications
-
Shock, Septic / drug therapy*
-
Surgical Wound Dehiscence
-
Vasoconstrictor Agents / therapeutic use
Substances
-
Adrenal Cortex Hormones
-
Fibrinolytic Agents
-
Protein C
-
Recombinant Proteins
-
Vasoconstrictor Agents
-
drotrecogin alfa activated